XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 106 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,331,000 | -34.2% | 572,963 | -27.1% | 0.00% | -100.0% |
| Q1 2021 | $3,543,000 | +0.2% | 785,701 | +9.3% | 0.00% | 0.0% |
| Q4 2020 | $3,537,000 | -2.2% | 719,004 | +17.8% | 0.00% | 0.0% |
| Q3 2020 | $3,618,000 | +180.5% | 610,204 | +25.8% | 0.00% | – |
| Q2 2020 | $1,290,000 | +35.4% | 485,086 | -0.8% | 0.00% | – |
| Q1 2020 | $953,000 | -80.9% | 488,936 | -31.0% | 0.00% | -100.0% |
| Q4 2019 | $4,996,000 | +50.2% | 708,924 | +109.4% | 0.00% | 0.0% |
| Q3 2019 | $3,327,000 | -10.1% | 338,510 | +4.6% | 0.00% | 0.0% |
| Q2 2019 | $3,702,000 | +36.7% | 323,676 | +19.9% | 0.00% | 0.0% |
| Q1 2019 | $2,709,000 | -3.6% | 269,882 | +63.2% | 0.00% | – |
| Q4 2018 | $2,810,000 | +137.9% | 165,384 | +146.0% | 0.00% | – |
| Q3 2018 | $1,181,000 | – | 67,233 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |